Dolostop 500 mg oral solution
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
Package leaflet: Information for the user
Dolostop 500 mg oral solution
Paracetamol
Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.
Follow exactly the instructions for administration provided in this leaflet or those given by your doctor, pharmacist, or nurse.
- Keep this leaflet, as you may need to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are effects not listed in this leaflet. See section 4.
- You should consult a doctor if symptoms worsen or if fever persists for more than 3 days or pain for more than 5 days.
Leaflet contents
- What Dolostop is and what it is used for
- What you need to know before taking Dolostop
- How to take Dolostop
- Possible adverse effects
- How to store Dolostop
- Contents of the pack and other information
1. What Dolostop is and what it is used for
Dolostop contains paracetamol. Paracetamol is effective in reducing pain and fever.
It is used for the relief of mild to moderate occasional pain, such as headache, dental pain, muscle pain (cramps), or back pain (lumbago), as well as in febrile conditions in adults and children weighing more than 33 kg (approximately 10–12 years of age).
2. What you need to know before starting to take Dolostop
Do not take Dolostop
- If you are allergic to paracetamol or to any of the other components of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take this medicine.
- Do not take more medicine than the recommended dose stated in section 3, How to take Dolostop.
- Avoid using this medicine together with other medicines containing paracetamol, such as cold and flu remedies, as high doses may cause liver damage. Do not use more than one medicine containing paracetamol without consulting your doctor.
- Chronic alcoholics should take care not to exceed 2 g of paracetamol in 24 hours.
- Patients with kidney, liver, heart, or lung diseases, or those with anemia (reduced hemoglobin levels in the blood, with or without a reduction in red blood cells), or patients suffering from chronic malnutrition or dehydration, should consult their doctor before taking this medicine.
- If you are being treated with antiepileptic drugs, consult your doctor before taking this medicine, as concomitant use may reduce efficacy and increase the hepatotoxicity of paracetamol, especially with high-dose paracetamol regimens.
- Asthmatic patients who are sensitive to acetylsalicylic acid should consult their doctor before taking this medicine.
During treatment with Dolostop, inform your doctor immediately if:
You have serious conditions such as severe renal failure or sepsis (when bacteria and their toxins circulate in the blood, causing organ damage), or if you suffer from malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A serious condition known as metabolic acidosis (an abnormality in blood and body fluids) has been reported in patients in these situations when paracetamol is used at regular doses over a prolonged period or when paracetamol is taken together with flucloxacillin. Symptoms of metabolic acidosis may include: severe breathing difficulty with deep and rapid breathing, drowsiness, malaise (nausea), and vomiting.
Children and adolescents
For children and adolescents under 10–12 years of age, consult your doctor or pharmacist, as other formulations with doses appropriate for these patients may be available.
Other medicines and Dolostop
Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
In particular, if you are taking any of the following medicines, your dose may need to be adjusted or treatment discontinued:
- Medicines to prevent blood clots: Oral anticoagulants (acenocoumarol, warfarin).
- Medicines for epilepsy: Antiepileptics (lamotrigine, phenytoin or other hydantoins, phenobarbital, methylphenobarbital, primidone, carbamazepine).
- Medicines for tuberculosis (isoniazid, rifampicin).
- Medicines for depression and seizures: Barbiturates (used as hypnotics, sedatives, and anticonvulsants).
- Medicines to lower blood cholesterol levels (cholestyramine).
- Medicines used to increase urine output (loop diuretics such as furosemide).
- Medicines used to treat gout (probenecid and sulfinpyrazone).
- Medicines used to prevent nausea and vomiting: Metoclopramide and domperidone.
- Medicines used to treat high blood pressure (hypertension) and heart rhythm disorders (cardiac arrhythmias): Propranolol.
- Flucloxacillin (antibiotic), due to a serious risk of blood and fluid imbalance (called metabolic acidosis with high anion gap), which requires urgent treatment (see section 2).
Do not use with other analgesics (medicines that relieve pain) without consulting your doctor.
As a general rule for any medicine, it is advisable to systematically inform your doctor or pharmacist if you are taking other medicines. In patients on oral anticoagulants, paracetamol may occasionally be used as the analgesic of choice.
Interference with laboratory tests
If you are due to have any laboratory tests (including blood and urine tests, etc.), inform your doctor that you are taking this medicine, as it may alter test results.
Paracetamol may alter the analytical values of uric acid and glucose.
Use of Dolostop with food, drinks, and alcohol
Using paracetamol in patients who habitually consume alcohol (three or more alcoholic drinks per day—beer, wine, spirits, etc.) may cause liver damage.
Taking this medicine with food does not affect its efficacy.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
Taking medicines during pregnancy may be harmful to the embryo or fetus and should be monitored by your doctor.
Paracetamol passes into breast milk; therefore, women who are breastfeeding should consult their doctor or pharmacist before taking this medicine.
Driving and using machines
The effect of paracetamol on the ability to drive and use machines is none or negligible.
Dolostop contains sorbitol (E-420), propylene glycol (E-1520), sulphites, glucose, and ethanol
This medicine contains 2,000 mg of sorbitol per sachet. If your doctor has told you (or your child) that you have an intolerance to certain sugars, or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which the patient cannot break down fructose, consult your doctor (or your child’s doctor) before taking this medicine. Sorbitol may cause gastrointestinal discomfort and a mild laxative effect.
This medicine contains 2,500 mg of propylene glycol per sachet.
If you are pregnant or breastfeeding, do not take this medicine unless recommended by your doctor. Your doctor may carry out additional monitoring while you are taking this medicine.
If you have hepatic or renal insufficiency, do not take this medicine unless recommended by your doctor. Your doctor may carry out additional monitoring while you are taking this medicine.
This medicine may cause severe allergic reactions and bronchospasm (sudden sensation of suffocation) because it contains ammonium sulphite caramel.
This medicine contains glucose (in maltodextrin derived from potato). If your doctor has told you that you have an intolerance to certain sugars, consult your doctor before taking this medicine.
This medicine contains 0.2% ethanol (alcohol), corresponding to 18.2 mg per sachet.
3. How to take Dolostop
Follow exactly the instructions for use provided in this leaflet or those given by your doctor. If in doubt, ask your doctor, pharmacist, or nurse.
The recommended dose is:
Adults:
Take 1 sachet (500 mg of paracetamol) every 4–6 hours as needed. If necessary, 2 sachets may be taken every 8 hours.
Do not exceed 3 g (6 sachets) in 24 hours. Doses should be spaced at least 4 hours apart.
Always take the lowest effective dose.
This medicine should only be taken when pain or fever occurs. As symptoms subside, treatment should be discontinued.
Prolonged use of high daily doses of paracetamol should be avoided, as it increases the risk of adverse effects such as liver damage.
If pain persists for more than 5 days, fever for more than 3 days, or if pain or fever worsen or new symptoms appear, discontinue treatment and consult your doctor.
For sore throat, do not take this medicine for more than 2 consecutive days without consulting your doctor.
Patients with kidney disease:
You must consult your doctor before taking this medicine.
Take a maximum of 1 sachet per dose.
Depending on your condition, your doctor will advise whether you should take the medicine with a minimum interval of 6 or 8 hours between doses.
Patients with liver disease:
You must consult your doctor before starting this medicine.
Take only the amount prescribed by your doctor, with a minimum interval of 8 hours between doses.
Do not exceed 2 g of paracetamol (4 sachets) in 24 hours, divided into several doses.
Children:
The recommended daily dose of paracetamol is approximately 60 mg/kg/day, divided into 4 or 6 doses per day, i.e., 15 mg/kg every 6 hours or 10 mg/kg every 4 hours.
It is necessary to respect the dosage guidelines based on body weight. The age of the child corresponding to weight is provided for informational purposes only.
- Children weighing between 33 kg and 42 kg (approximately 10 to 12 years): 1 sachet per dose every 6 hours, up to a maximum of 4 sachets per day.
- Children weighing between 42 kg and 50 kg (approximately 12 to 14 years): 1 sachet per dose every 4–6 hours as needed, up to a maximum of 5 sachets per day.
Do not use for more than 3 consecutive days in children without reassessing the clinical condition.
Do not use in children weighing less than 33 kg (approximately 10–12 years). The use of other more suitable formulations is recommended for treating this patient group.
Method of administration
This medicine is taken orally.
The contents of the sachet may be taken diluted in a liquid, preferably water, or taken directly.
Once the sachet is opened, consume all of its contents.
If you take more Dolostop than you should
Contact your doctor or pharmacist immediately. In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service (telephone 91 562 04 20), stating the name of the medicine and the amount ingested.
Symptoms of overdose may include: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), and abdominal pain.
If you have taken an overdose, you should go immediately to a medical center even if you do not have symptoms, as symptoms often do not appear until 3 days after the overdose, even in cases of severe poisoning.
Treatment for overdose is most effective if started within 4 hours of ingestion.
Patients undergoing treatment with barbiturates or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
If you forget to take Dolostop
Do not take a double dose to make up for a missed dose.
4. Possible adverse effects
Like all medicines, this medicine may cause adverse effects, although not everyone experiences them.
Rare adverse effects (may affect up to 1 in 1,000 people): malaise, drop in blood pressure (hypotension), and increased blood transaminase levels.
Very rare adverse effects (may affect up to 1 in 10,000 people): kidney disorders, cloudy urine, allergic dermatitis (skin rash), jaundice (yellowing of the skin), blood disorders (agranulocytosis, leucopenia, neutropenia, haemolytic anaemia), hypoglycaemia (low blood sugar), and severe skin reactions.
Adverse effects with unknown frequency (cannot be estimated from available data): A serious condition that may cause the blood to become more acidic (called metabolic acidosis) in patients with severe illness who use paracetamol (see section 2).
Paracetamol may damage the liver when taken at high doses or during prolonged treatment.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicinal Products: www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Dolostop
Keep this medicine out of the sight and reach of children.
Store below 30°C.
Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date refers to the last day of the month indicated.
Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to properly dispose of unused medicines and their packaging. This will help protect the environment.
6. Contents of the pack and other information
Composition of Dolostop
- The active substance is paracetamol. Each sachet contains 500 mg of paracetamol.
- The other components are: propylene glycol (E1520), macrogol 400, povidone K12, sorbitol (E420), ammonium sulfite caramel (E150d) (containing corn maltodextrin), masking SC274292 (containing sucralose (E955), maltodextrin (from potato) and monoammonium glycyrrhizinate), neohesperidin dihydrochalcone (E959), orange flavour (containing ethanol), citric acid monohydrate (for pH adjustment) and purified water.
Appearance of Dolostop and contents of the pack
Brown oral solution, packed in single-dose sachets.
Each pack contains 10 or 20 sachets, presented in thermoformed blisters made of an aluminum complex (polyester/aluminum/polyethylene, polyester and polyethylene).
Only certain pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Date of the most recent revision of this leaflet: February 2025
Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/